Can HNMT and AOC1 variants reduce histamine breakdown and strengthen histamine signaling?

Histamine homeostasis relies on a precise balance between its release from immune cells and its clearance by key degrading enzymes. Genetic variations in the genes encoding these enzymes can significantly disrupt this balance, leading to systemic accumulation and heightened physiological sensitivity.

Genetic determinants of histamine clearance

• AOC1/DAO variants: The AOC1 gene encodes diamine oxidase (DAO), which clears extracellular histamine in the gut. The rs10156191 (Thr16Met) variant, particularly in homozygous individuals, drastically reduces DAO catalytic activity. This allows unmetabolized dietary and bacterial histamine to cross the intestinal mucosa and enter systemic circulation.
• HNMT variants: The HNMT gene encodes histamine N-methyltransferase, which neutralizes histamine intracellularly. The rs11558538 (Thr105Ile) missense mutation destabilizes the HNMT protein, severely decreasing its enzymatic activity in vital tissues like the lungs, skin, and central nervous system.

Impact on basophil signaling and feedback

• Amplified signaling: Basophils are the primary source of circulating histamine. When basophils degranulate, the absence of efficient DAO or HNMT clearance causes histamine to accumulate in the extracellular space. This "hyperhistaminaemia" prolongs and intensifies downstream receptor binding, magnifying allergic and inflammatory symptoms.
• Feedback modulation: Chronically elevated baseline histamine levels resulting from impaired degradation can also modulate basophil function. By altering local feedback mechanisms, this persistent histamine milieu lowers the activation threshold, making basophils more sensitive to subsequent stimuli.

Bottom line

• Genetic variants in AOC1 (rs10156191) and HNMT (rs11558538) impair extracellular and intracellular histamine clearance. This enzymatic deficit directly prolongs the lifetime of histamine released by basophils, significantly amplifying and lengthening downstream inflammatory signaling.